MM-398

liposomal irinotecan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MM-398, covering 2017-01-31 to 2017-01-31. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer [Phase 1]